surmount 5 tirzepatide vs Semaglutide: SURMOUNT-5 Results SURMOUNT-5 Trial: Tirzepatide vs Semaglutide

Primary research areas Anabolic signaling and myogenesis studies

Roche announced today positive topline results from two arms of an ongoing multi-part Phase I clinical trial for CT-996, an investigational, once-daily, oral small molecule GLP-1 receptor agonist being developed for the treatment of both type 2 diabetes and obesity

Godoy-Matos AF: The role of glucagon on type 2 diabetes at a glance

Identifying potential novel drugs against helicobacter pylori by targeting the essential response regulator hsra

In this article, well break down the differences, benefits, and considerations between Mounjaro and Ozempic, so you can make an informed decision about the best weight loss option for you